These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38697027)

  • 1. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
    Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
    Dermatology; 2024; 240(4):671-683. PubMed ID: 38697027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
    Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
    Drugs Context; 2023; 12():. PubMed ID: 36660014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.
    Shenoy MM; De A; Shah B; Das A; Saraswat A; Lahiri K; Yadav S; Sarda A; Chakraborty D; J D; Kamat S; Doshi Y; Gonsalves N; Choudhary A; Dhoot D; Mahadkar N; Bhushan S; Gadkari R; Barkate H
    Drug Des Devel Ther; 2023; 17():2899-2908. PubMed ID: 37766823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.
    Shenoy M; Dhoot D; Mahajan H; Barkate H
    Clin Cosmet Investig Dermatol; 2021; 14():1367-1376. PubMed ID: 34611418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
    Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
    BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
    Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
    Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
    Shah B; Mistry D; Jairam D; Kansara K; Pandya R; Vasani P; Dhoot D; Mahadkar N; Bhushan S; Barkate H
    Infect Drug Resist; 2023; 16():2409-2416. PubMed ID: 37125212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study.
    Jain GK; Chitnis KR; Singhal P; Mahadkar N; Dhoot D; Barkate H
    Cureus; 2023 Apr; 15(4):e37462. PubMed ID: 37187635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUBA-itraconazole in the treatment of systemic fungal infections.
    Liu J; Vanderwyk KA; Donnelley MA; Thompson Iii GR
    Future Microbiol; 2024 Sep; 19(13):1171-1175. PubMed ID: 39011995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
    Sardana K; Mathachan SR
    Indian Dermatol Online J; 2021; 12(1):1-5. PubMed ID: 33768016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
    Sharma P; Bhalla M; Thami GP; Chander J
    J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale.
    Carmo PHF; Costa MC; Leocádio VAT; Gouveia-Eufrásio L; Emídio ECP; Pimentel SP; Paixão TA; Peres NTA; Santos DA
    Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36367546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
    Rana DK; Shah TS; Rohit MH; Patel NH; Khadela AD; Oza YP; Padhiyar JK
    Mycoses; 2024 Jan; 67(1):e13681. PubMed ID: 38214352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
    Shenoy M; De A; Shah B; Das A; Saraswat A; Lahiri K; Dhoot D
    Indian Dermatol Online J; 2023; 14(6):839-843. PubMed ID: 38099030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis.
    Hassaan ZRAA; Mohamed HAK; Eldahshan RM; Elsaie ML
    Sci Rep; 2023 Nov; 13(1):19037. PubMed ID: 37923859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
    Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
    Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two systemic antifungal agents, itraconazole and terbinafine, for the treatment of dermatophytosis in European hedgehogs (Erinaceus europaeus).
    Bexton S; Nelson H
    Vet Dermatol; 2016 Dec; 27(6):500-e133. PubMed ID: 27620985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Dermatophytosis: Real-World Indian Perspective.
    Shenoy M; Poojari S; Rengasamy M; Vedmurthy M; Barua S; Dhoot D; Barkate H
    Indian Dermatol Online J; 2023; 14(3):347-356. PubMed ID: 37266073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.